Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Evangelicals And Israelis Team Up For Medicinal Weed

Evangelical Christians are collaborating with Israelis to launch a line of medicinal cannabis products.

Zytecur, a US-based company owned by Evangelicals, is teaming up with bio-tech companies in Israel to develop a product line that will “alleviate numerous health concerns, including epilepsy and cancer, available immediately online,” according to a press release.

“God led me to enter the medical cannabis market, conquer it, and use the proceeds to build the Kingdom of Christ,” said Chris Clark, a founder of Zytecur.

The products were developed using research by IlanBio Cultures, an American-Israeli operated corporation with headquarters in Hollister, California, and Tel Aviv. Among other ailments the products aim to treat is post-traumatic stress disorder.

Clark and his partners in Zytecur are all “followers of Christ, as well as U.S. Marine Corps combat veterans who served in the Special Operations in the Iraq war,” a press release from the company read.

Email Sam Kestenbaum at [email protected]

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.